CRBP7:00 AMCorbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical CancersTrial Results • Phase 1/2Updated clinical data release Tue, May 26, 2026, 7:00 AM EDTGcorbuspharma.com